You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

Not yet recruiting
  • Pancreatic Neoplasms
  • Shanghai, China
    Fudan University ShangHai Cancer Center
Jul 31, 2023

First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,

Not yet recruiting
  • First-line Treatment of Advanced Pancreatic Cancer
  • HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
  • nab-paclitaxel; gemcitabine
  • (no location specified)
Feb 28, 2023

Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)

Recruiting
  • Pancreatic Neoplasms
  • Utidelone injection in combination with gemcitabine
  • Shanghai, Shanghai, China
    Shanghai First People's Hospital
Mar 21, 2023

Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono

Completed
  • Metastatic Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • nab-paclitaxel and gemcitabine
  • gemcitabine mono and nab-paclitaxel and gemcitabine
  • Weiden, Germany
    Kliniken Nordoberpfalz AG, Klinikum Weiden
Nov 21, 2022

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

Recruiting
  • Pancreatic Cancer
  • surufatinib + gemcitabine + nab-paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 15, 2023

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Pancreatic Cancer Trial in Meldola, Ravenna (Losartan, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Meldola, Forlì, Italy
  • +1 more
May 12, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
  • Gemcitabine hydrochloride and albumin binding paclitaxel
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Dec 8, 2022

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Pancreas Cancer Trial (surufatinib + camrelizumab + nab-paclitaxel + S-1, nab-paclitaxel + gemcitabine)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • surufatinib + camrelizumab + nab-paclitaxel + S-1
  • nab-paclitaxel + gemcitabine
  • Beijing, China
    Chinese PLA General Hospital
Sep 26, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

Active, not recruiting
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 29, 2022

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

Recruiting
  • Locally Advanced Pancreatic Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)

Recruiting
  • Urinary Bladder Cancer
  • Carboplatin-Gemcitabine Cisplatin-Gemcitabine
  • Assiut, Egypt
    AssiutU
Apr 22, 2023

Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

Completed
  • Resectable Pancreatic Cancer
  • Ductal Adenocarcinoma of the Pancreas
  • perioperative nab-paclitaxel/gemcitabine
  • adjuvant nab-paclitaxel/gemcitabine
  • Ulm, Germany
    University of Ulm, Dept. of Internal Medicine I
Nov 21, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023

Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

Recruiting
  • Borderline Resectable Pancreatic Cancer
  • Locally Advanced Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022